NASDAQ
OFIX
Last Price
US $10.18
KEY FIGURES
MKT CAP
$411.5M
EPS
TTM
$-1.51
EPS Growth (1Y)
-30.91%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
0.50x
YIELD
-
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Orthofix Medical Inc. cash flow to debt ratio of 14.55% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Orthofix Medical Inc.'s free cash flow has increased -85.92% from $-9.09M last year to $-1.28M, signaling increasing performance
Debt-to-equity ratio
Orthofix Medical Inc.'s debt to equity ratio is 0.55, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Orthofix Medical Inc.'s debt has increased relative to shareholder equity from 0.36 last year to 0.55 today, signaling weakened financials
Net debt to EBITDA
Orthofix Medical Inc. has negative EBITDA, making leverage ratio unreliable
Interest coverage
Orthofix Medical Inc.'s interest coverage ratio is -1.22, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Orthofix Medical Inc.'s profit margin has increased (-52.99%) in the last year from -15.76% to -7.41%, signaling increasing performance
Current ratio
Orthofix Medical Inc.'s short-term assets of $416.85M exceed its short-term liabilities of $170.48M
Return on assets
Orthofix Medical Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Orthofix Medical Inc.'s return on equity of -14.05%, is lower than 15.00%, indicating bad performance
Earnings quality
Orthofix Medical Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Orthofix Medical Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
Orthofix Medical Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Orthofix Medical Inc. has negative free cash flow, indicating cash burn
Earnings growth
Orthofix Medical Inc.'s yearly earnings has increased -26.83% since last year from $-126.00M to $-92.19M, signaling increasing performance
Revenue growth
Orthofix Medical Inc.'s yearly revenue has increased 2.85% since last year from $799.49M to $822.31M, signaling increasing performance
Return on invested capital
ROIC -3.55% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Orthofix Medical Inc.'s 3-year revenue CAGR of 21.30% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Orthofix Medical Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Orthofix Medical Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
Orthofix Medical Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Orthofix Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Orthofix Medical Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Orthofix Medical Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Orthofix Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Orthofix Medical Inc. has a price-to-book ratio of 0.98x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Orthofix Medical Inc. has a price-to-sales ratio of 0.50x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-14.05%
Return on equity
ROIC: -3.55%
Valuation History
-
Price to Earnings
EV/EBITDA: 5.1X
Cash flow
Profit margin
15.13%
EBITDA
-
Cash flow
-
Cash Flow (DCF)
Fair Value
Market $10.18
—
Default assumptions
EBITDA Multiple
Fair Value
Market $10.18
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.